Sagimet Biosciences Inc (NASDAQ:SGMT) currently has a daily average trading volume of 483.15K but it saw 948484 shares traded in last market. With a market cap of 107.36M USD, the company’s current market price of $3.50 came rising about 2.94 while comparing to the previous closing price of $3.40. In past 52 weeks, the stock remained buoying in the range of price level as high as $7.38 and as low as $1.73.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Oppenheimer which initiated the stock as “Outperform” in its note to investors issued on December 06, 2024, recommending a price target of $30 for it. Goldman issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $23 and $6.
Over the week, SGMT’s stock price is moving 8.70% up while it is 2.34% when we observe its performance for the past one month. Year-to-date it is -22.22% down and over the past year, the stock is showing a downside performance of -27.39%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of -0.5 while estimate for next year EPS is -2.27.
Currently, Sagimet Biosciences Inc’s total number of outstanding shares is 30.67M with 8.40% of that held by the insiders while 45.73% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -41.09% and return on equity (ROE) at -34.72%. Stock’s beta reads 2.20. Stock has a price to book (P/B) ratio of 0.81. Its return on asset (ROA) is -33.53% on average.
